Intrinsic Value of S&P & Nasdaq Contact Us

Aclarion, Inc. ACONW NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
46/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Aclarion, Inc. (ACONW) has a negative trailing P/E of -0.3, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -352.23%.

Criteria proven by this page:

  • VALUE (100/100, Pass) — composite valuation score exceeds the 60/100 pass threshold.
  • Trailing Earnings Yield -352.23% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.

Overall SharesGrow Score: 44/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
46/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
N/A
No coverage
PAST
0/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
MOAT
0/100
→ Income
GROWTH
63/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — ACONW

Valuation Multiples
P/E (TTM)-0.3
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio27.18
EV/EBITDA1,689,966.3
Per Share Data
EPS (TTM)$-13.60
Book Value / Share$24,124,527.29
Revenue / Share$0.14
FCF / Share$-13,465,637.66
Yields & Fair Value
Earnings Yield-352.23%
Dividend Yield0.00%

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2019 -4.9 0.00 -11.48 726.15 -
2020 -4.2 -0.32 -2.76 401.45 -
2021 -3.9 -0.46 -3.41 323.95 -
2022 -0.5 -0.01 1.59 58.59 -
2023 -0.4 0.01 -2.45 23.63 -
2024 0.0 0.00 0.13 2.69 -
2025 -0.3 0.00 0.00 32.32 221,666.92%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2019 $-97,680.00 $26.9K $-4.02M -14961.1%
2020 $-110,583.00 $48.65K $-4.79M -9846.2%
2021 $-120,035.00 $60.29K $-3.53M -5862.5%
2022 $-177,396.00 $60.44K $-9.11M -15074.7%
2023 $-79,782.00 $75.4K $-4.91M -6513.4%
2024 $-7,480.21 $45.72K $-6.99M -15293.8%
2025 $-13.61 $75.73K $-7.23M -9551.9%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-4.37 $-4.37 – $-4.37 $139K $139K – $139K 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message